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Abstract.  Deletion of the c-src gene in transgenic 
mice by homologous recombination leads to osteo- 
petrosis,  a  skeletal defect characterized by markedly 
deficient bone resorption (Soriano, P., C. Montgomery, 
R. Geske, and A. Bradley.  1991.  Cell.  64:693-702), 
demonstrating  a critical functional role of pp60  ~-s'~ in 
osteoclast activity.  Since decreased bone resorption 
could result from a defect either within the osteoclast 
or within other cells present in its environment,  indi- 
reedy affecting osteoclast functions, we determined 
which cell(s) in bone expressed high levels of pp60  "-'~ 
Measuring pp60  ~-~'~ protein and kinase activities in 
osteoclasts and immunolocalizing pp60  ~-'~ in bone, we 
find that expression of pp60  ~'= is nearly as high in 
osteoclasts as in brain and platelets.  In contrast,  other 
bone cells contain only very low levels of the protein. 
In addition,  expression of the c-src gene product in- 
creases when bone marrow cells are induced to ex- 
press an osteoclast-like phenotype by 1,25-dihydroxy- 
vitamin D3, further suggesting that high expression of 
pp60  "-'~ is part of the osteoclast phenotype. Three 
other src-like kinases, c-fyn, c-yes,  and c-lyn, are also 
expressed in osteoclasts at ratios to pp60  ~s~ similar to 
what is found in platelets.  These src-related proteins 
do not, however, compensate for the absence of 
pp60  .... in the src- mice, thereby suggesting that 
pp60  ~-'~ may have a  specific function in osteoclasts. 
Although further work is necessary to elucidate what 
the critical role of pp60  ~s'~ in osteoclasts is, our obser- 
vation that the protein is associated mostly with the 
membranes of intracellular organdies suggests the pos- 
sibility that this role might be at least in part related 
to the targeting or fusion of membrane vesicles. 
T 
HE c-src protooncogene is highly conserved through- 
out evolution and widely expressed (9, 14). While the 
level  of expression is low in  most cells,  some cell 
types, particularly neurons (10) and blood platelets (20, 47), 
express the  gene product  (pp60~-s'  0  and  the  c-src  kinase 
activity at high  levels.  Although the physiological  role of 
pp60  "-s~ is not fully understood (9, 14, 35), it is known that 
pp60  ~-s~ and the other members of the src  family,  which 
share highly conserved sequences both within  and outside 
the kinase catalytic domain, play important roles in signal 
transduction mechanisms that contribute to the regulation of 
cell growth and development (6, 9). They can be activated 
by various transmembrane tymsine-kinase receptors, such 
as the PDGF receptor (28), and in turn, phosphorylate vari- 
ous substrate proteins on tyrosine residues, including the ras 
GTPase activating  protein (9,  15),  one of the subunits  of 
the IPs-kinase  (p85)  (17, 23) and two proteins with relative 
molecular masses of 80 kD and 85 kD,  which colocalize 
with F-actin in peripheral extensions  of normal cells and in 
matrix  attachment  structures  (podosomes) in  v-src-trans- 
formed cells (50). 
To better understand the physiological  role of pp60  ~-s'~, 
Soriano et al. (41) have performed the targeted disruption of 
its encoding gene by homologous recombination in mouse 
embryos.  Surprisingly,  cell  proliferation  and  other  basal 
functions did not seem to be altered in the mutant c-src- 
mice and no obvious phenotypic or functional abnormalities 
were noticed in brain and other neuronal  tissues or in plate- 
lets, possibly due to the presence in these cells of other src- 
like tyrosine kinases,  e.g., c-fyn and/or c-yes, which might 
impart  a  degree  of functional  redundancy  with  ppt0~-src 
(41).  Unexpectedly,  striking  skeletal abnormalities  with a 
phenotype of osteopetmsis were observed in the recombinant 
mice.  These included a  failure  of the incisors  to erupt,  a 
slower growth, shorter and abnormally shaped long bones, 
and a decreased bone marrow cavity. All these changes are 
characteristic of impaired osteoclast activity (33). The pres- 
ence of osteoclasts in  apparently  normal  numbers  in  the 
c-src- animals  suggested  that the defect was with the func- 
tion rather than the differentiation  of the cells.  These data 
therefore suggested a critical role of normal c-src expression 
in  osteoclast function,  and  the  lack of other  phenotypic 
changes in these mutant mice suggested that the requirement 
for normal c-src expression in bone was more stringent than 
in other tissues.  The failure of osteoclasts of c-src- mice to 
resorb bone at a normal rate could, however, be due either 
to alterations  within the osteoclasts or to alterations  in other 
cells, which would be necessary for the complete differentia- 
tion or activation of the osteoclast (43). This study was con- 
sequently undertaken to determine the cellular and subcellu- 
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pp60  r  is expressed at high levels in osteoclasts,  where it 
is  associated  predominantly  with intracellular  organelles, 
but not in other bone cells. Osteoclasts were also found to 
express c-fyn, c-lyn, and c-yes. Culturing bone marrow cells 
with  1,25  dihydroxyvitamin  D3  (1,25(OH):D3),  l which in- 
duces differentiation  into osteoclast-like cells (4, 5), resulted 
in increased expression of pp60  r  These results, taken to- 
gether with the observation of Soriano et al.  (41),  suggest 
that pp60  r  is part  of the  osteoclast phenotype  and may 
perform a function associated with intracellular vesicles in 
the osteoclast that is essential for normal bone resorption. 
Materials and Methods 
Cell and 1Issue Preparation 
All buffers used for cell isolation and lysis contained protease inhibitors (0.1 
mM PMSF, 1 #M pepstatin, and 1 #M leupeptin). Osteoclasts were isolated 
from adult laying hens fed a calcium-deficient diet for 14 d (51). Tibias and 
femurs were quickly dissected and placed in ice-cold phosphate-buffered  sa- 
line containing 0.1%  bovine serum albumin (PBS-BSA). All subsequent 
steps were performed on ice. After splitting the bone longitudinally, the 
medullary bone was removed and rinsed with PBS-BSA to remove bone 
marrow ceils, and then minced, and the cells were dissociated from the bone 
fragments by shaking. The resulting suspension was filtered through 100- 
#m nylon mesh to separate the cells from the bone fragments. The bone 
fragments were resuspended in PBS-BSA and the process was repeated four 
times. Pooled filtrates were centrifuged at 150 g for 5 rain. The cell pellet 
was resuspended in 0.25% NaC1 (10 ml per hen) and kept on ice for 7 min 
with mild vortexing every 90 s to lyse erythrocytes. After adding an equal 
volume of 1.6% NaC1, the final cell suspension was passed through a 50-~m 
nylon mesh to remove debris and the cells were recovered by centrifugation 
at 150 g for 5 rain. The pelleted cells were resuspended in PBS-BSA (15 
ml/hen; sample OC1) and layered over 30 ml of 70% heat-inactivated fetal 
bovine serum, 30% c~MEM and kept on ice for 80 rain to permit the os- 
teoclasts to sediment at unit gravity.  The top 20 ml was removed to a clean 
tube (sample OC2S) and the remaining 20 ml was centrifuged at 150 g for 
5 rain. The partially purified osteoclast pellet was then resuspended in PBS- 
BSA  (15  ml/hen;  OC2P),  layered  over  30  ml  of  100%  FBS  (heat- 
inactivated), and kept on ice for an additional 40 rain. The top 25 ml was 
aspirated, and the remaining 15 ml in the tube was centrifuged as before, 
generating an osteoclast preparation (OC3) that was used immediately or 
kept frozen at -70"C for future use. On average, the starting cell suspension 
contained approximately one osteoclast/500-1,000 cells. After the first unit 
gravity sedimentation, the purity was 1 osteoclast to 100-150 other ceils. 
In the final osteoclast preparation the purity was 1 osteoclast to 5-10 con- 
taminating cells. Since unit gravity sedimentation favored the selection of 
the much larger osteoclasts, we estimate that '~90% of the protein in these 
preparations was derived from osteoclasts. 
Whole chicken brain was removed and minced in ice-cold PBS-BSA. The 
minced tissue was homogenized in a Dounce homogenizer with a loose- 
fitting pestle in 5 vol of ice-cold RIPA buffer (29) or PBS containing 0.5 % 
SDS, and insoluble material was removed by centrifugation for 15 min at 
27,OOO g. 
Platelets were isolated from chicken and human blood anticoagulated 
with 1:10 vol of 3.8%  sodium citrate. All procedures were performed at 
room temperature to minimize platelet activation and subsequent aggrega- 
tion during centrifugation. The blood was centrifuged for 10 rain at 190 g, 
and the platelet-rieh plasma was removed to a clean tube. The platelets were 
washed in PBS containing 5 mM EGTA and the final pellet was lysed in 
either RIPA buffer or PBS containing 0.5%  SDS. 
Bone Marrow Cell Cultures 
Bone marrow cells were isolated from the tibias and femurs of  white leghorn 
chickens (SPAFAS, Norwich, CT) that had been fed a calcium-deficient  diet 
(Ralston Purina, Richmond, IN) for 1-2 wk after hatching in c~MEM con- 
1. Abbreviations  used in this paper: 1,25(OI-I)2D3, 1,25 dihydroxyvitamin 
1)3; PLP, paraformaldehyde, lysine, sodium periodate. 
taining  2%  heat-inactivated chicken  serum  (Sigma  Chemical  Co.,  St. 
Louis, MO),  8% heat-inactivated FBS (Sigma Chemical Co.), 50 UI/ml 
penicillin, and 50 #g/ml streptomycin. Mononuclear cells were fractionated 
on Ficoll-Paque (Pharmacia LKB Biotechnology, Inc., Piscataway,  NJ) by 
sedimentation to the medium-Ficoll interface. To deplete these prepara- 
tions of the most mature stromal and myelomonocytic cells, isolated cells 
were plated for 16 h at 5  x  106 cells/nil in the same medium used in the 
isolation procedure (3). Nonadherent cells were recovered after 16 h of cul- 
ture,  replated in  150-mm tissue culture plates at  a  density of 6  ￿  106 
cells/ml (8  x  1@  s cells/cm2), and cultured for 2-6 d. Ceils were grown in 
the presence or absence of 10  -s M exogenous 1,25(OH)2D3  (provided by 
Dr. Milan Uskokovic, Hoffman-LaRoche, Nutley,  NJ). 
Western Blots 
Western blotting  (29,  46)  was  performed using  alkaline  phosphatase- 
conjugated goat  anti-mouse IgG  secondary  antibody  (Promega  Corp., 
Madison, WI), except when the amount of pp60  c's'c was to be quantitated, 
in which case biotinylated mAb 327 was used as the primary antibody and 
[l:5I]streptavidin (20-40 mCi/mg; Amersham Corp., Arlington Heights, 
IL) was used to detect the bands; mAb 327 was biotinylated using the Pierce 
biotinylation kit (Pierce Chemical Co.,  Rockford, IL)  according to the 
manufacturer's instructions. 
Imraunoprecipitation and Kinase Assay 
Kinase activity was measured by a method derived from those of Levy and 
Brugge (29) and Kypta et al. (28). Samples were lysed in RIPA buffer. Equal 
amounts of protein (200-400 #g) were incubated with antibody on ice for 
45  min,  and  the  immune  complexes  were  precipitated  with  protein 
A-agarose (for rabbit polyclonal antibodies) or protein G-agarose (for 
mouse mAbs). The beads were washed twice with RIPA buffer and once 
with 100  mM NaC1,  10 mM Tris, and 5  mM MgC12, pH 7.0. In some 
cases, immunoprecipitated pp60  ~-src was split into two equal portions, one 
to be used for assaying kinase activity and the other for Western blot to 
qnantitate the amount of pp60  ~-'r~ present. Kinase activity was measured 
by incubating the beads with 5 mg acid-denatured rabbit muscle enolase and 
100 mM [3,-32p]ATP (5 #Ci/sample) in 20 mM Hepes (pH 7.5) and 10 mM 
MnC12 for 15 rain on ice. The samples were subjected to SDS-PAGE on 
8% gels, which were stained, dried, and autoradiographed. 
Immunocytochemistry 
lmmunoperoxidase. White leghorn chickens (SPAFAS) that had been fed 
a calcium-deficient diet (Ralston Purina) for 1 wk after hatching, and 4-d- 
old Wistar rat pups were perfused, via the heart or the femoral artery, 
respectively, with PBS for 1 min, followed by paraformaldehyde (2 %), ly- 
sine (0.75 M), sodium periodate (0.01 M) (PLP) for 5 min. The proximal 
tibias were dissected out and slices were cut out of the primary spongiosa 
area under the growth plate. The slices were fixed in PLP for an additional 
4 h at 4~  and then washed in PBS containing 10% DMSO as a cryoprotec- 
tant. The tissue was subsequently quick-frozen and 40-~,m sections were 
prepared on a cryostat (Bright Instr.  Co., Ltd., Huntingdon, UK) using 
tungsten carbide knives. Sections were incubated overnight at 4~  in mAb 
327, a monoclonal antibody against chicken pp60  cs'~ (Oncogene Science, 
Inc., Manhasset, NY) diluted in PBS  +  0.1% BSA. 
After washing (2 h) in PBS +  0.1% BSA, the sections were incubated 
with Fab fragments of peroxidase-labeled goat anti-mouse IgG (Biosys, 
France). Sections were incubated with the secondary antibodies at a dilution 
of I:IOO in PBS +  0.1% BSA for 2 h at 20~  After washing, the sections 
were reacted in DAB (1 mg/ml in 0.05 M Tris buffer, pH 7.4; Polysciences 
Inc.,  Warrington,  PA) in the presence of 0.1%  H202  and post-fixed in 
ferrocyanide-reduced OsO4. After embedding in Epon (Polybed 812; Poly- 
sciences Inc.), l-~m-thick sections were cut with a glass knife and counter- 
stained with methylene blue-azure II for identification of areas of interest. 
Selected areas were then sectioned with a diamond knife and stained with 
lead citrate. Grids were viewed on a JEOL-CX 100 electron microscope 
(JEOL U.S.A. Inc., Peabody, MA). 
Imraunofluorescence Labeling.  For  immunofluorescence staining of 
bone tissue, white leghorn chickens maintained on a calcium-deficient diet 
for 1 wk after hatching were perfused with PLP as described above. The 
proximal tibias were dissected out and slices were cut out of the primary 
spongiosa area under the growth plate. The slices were fixed in PLP for an 
additional 4 h at 4~  washed in PBS for 1 h, and infiltrated overnight with 
30% sucrose in PBS. The tissue was subsequently quick-frozen, and 6-~m 
sections were prepared on a Bright cryostat using tungsten carbide knives 
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teoclasts,  osteoclasts  were isolated from 4-d-old Wistar  rat pups as de- 
scribed elsewhere (42) and cultured overnight on glass coverslips or slices 
of cortical bovine bone. The ceils were fixed in 3.7 % formaldehyde in PBS 
for 10 min at room temperature and washed with PBS. Further processing 
of tissue sections and isolated cells was identical. All subsequent incuba- 
tions  were performed  at room temperature  with PBS containing  0.05% 
saponin and 5 % normal goat serum.  The samples were incubated for 1 h 
with PBS-saponin-normal goat serum to block nonspecific binding, then for 
1 h with mAb 327 diluted 1:25. The samples were washed with PBS-saponin 
and  incubated  with  rhodamine-conjugated  goat  anti-mouse IgG  (Boeh- 
ringer Mannheim Corp., Indianapolis, IN) for 1 h in the dark. After wash- 
ing with PBS, the samples were mounted in FluorSave (Calbiochem Corp., 
La Jolla,  CA).  Microscopy was performed using a confoeal microscope 
(model MRC 600; Bio-Rad Laboratories,  Richmond, CA) with a krypton 
laser. 
Immunogold Labeling.  Immunogold  labeling  was performed by the 
method of  Tokuyasu (45), with some  modifications. White leghorn chickens 
maintained on a caicium-deficient diet for 1 wk after hatching were perfused 
with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for 5 rain. 
The proximal tibias were dissected out and the growth plate was removed 
and fixed by immersion in 4% paraformaldehyde plus 0.1% glutaraldehyde 
for 4 h at 4~  The fixed tissue was washed in PBS and infiltrated overnight 
in 2.3 M sucrose plus 15% polyvinylpyrolidone. Sections were cut on an 
ultracryotome  (Reichert Scientific Instruments,  Buffalo, NY).  Fixed sec- 
tions on grids were transferred to PBS containing 1% BSA for 30 min. All 
subsequent incubations were performed at room temperature.  Grids were 
incubated with mAb 327 diluted 1:25 in PBS +  1% BSA for 1 h, and then 
washed and incubated with a 1:50 dilution of  anti-mouse  IgG-colloidal gold 
complexes (10 nm; Amersham Corp.) for 15 rain. After washing in PBS, 
the grids were counterstained with uranyl acetate and embedded in methyl 
cellulose.  Grids  were  viewed  on  a  JEOL-CX100  electron  microscope 
OEOL U.S.A. Inc.). 
SubceUular Fractionation 
Osteoclasts were resuspended in 5 vol of ice-cold HARM's buffer (10 mM 
triethanol  amine,  10 mM acetic acid,  I  mM EDTA, pH 7.4) containing 
0.25 M sucrose and protease inhibitors and passed 8-10 times through a 25- 
gauge needle. The homogenate was centrifuged at 1,000 g for 10 rain and 
the supernatant  was centrifuged  at  10,000 g  for 10 re_in to pellet mito- 
chondria. The pellet was washed once in HARM's buffer. The 10,000 g su- 
pernatant was centrifuged at 100,000 g for 90 rain in a rotor (model SW41; 
Beckman Instruments, Inc., Fullerton, CA) to sediment microsomal mem- 
branes. The supernatant was retained and the pellet was washed by being 
resuspended in HARM's buffer without sucrose and centrifuged at 100,000 g 
for 90 rain. 
Northern Blots 
Total RNA from the bone marrow  cells cultured  with or without  1,25- 
(OH)2D3 for 6 d was isolated using the guanidium isothiocyanate method 
(7). Poly (A+) mRNA was purified from bone marrow total RNA using 
the PolyATract mRNA  isolation  system  (Promega  Corp.).  Formamide- 
denatured  poly (A+) mRNA was electrophoresed  on 1%  formaldehyde/ 
agarose gels and transferred to nylon membranes (Hybond N*; Amersham 
Corp.). Membranes were prehybridized for 30 rain at 65~  in rapid hybrid- 
ization buffer (Amersham Corp.) and hybridized in the same buffer with a 
gel-purified 1.65-kb cDNA probe encoding the chicken c-src (30) for 2 h 
at 65~  The probe was labeled with [o~-32p]dCTP  by nick translation (39). 
Membranes  were washed twice under high stringency conditions  in 2x 
SSC/0.1% SDS for 15 rain each at room temperature, and once each in 1￿ 
SSC/0.1% SDS and 0.1x  SSC/0.1% SDS for 30 rain at 65~  Membranes 
were exposed to x-ray film at -70~  using an intensifying screen. 
Protein Assay 
Protein concentrations were determined with the Micro BCA protein assay 
reagent (Pierce Chemical Co.). 
Antibodies 
mAb 327,  which recognizes  chicken  pp60  c-*'~  (32),  was obtained  from J. 
Brugge and Oncogene Science  Inc. A  second mAb  against  pp60  c-s'~, 
LA074, raised  against  residues  2-17 of  pp60  vs'~,  was obtained  from  Qual- 
ity Biologics  Inc.  (Camden, NJ).  Polyclonal  antibodies  against  the arc- 
related kinases were obtained from Drs. J. Bolen (c-blk, c-fgr, c-fyn, c-hck, 
c-lck, and c-/yn) (25), J. Brugge (c-yes), S. Courtneidge (c-yes) (28), and 
R. Perlmutter (c-fyn) (8). 
Results 
Immunoblotting and src Kinase Activity 
Osteoclasts were isolated from calcium-deficient hens and 
the proteins were immunoblotted with mAb 327. The results 
demonstrated that the characteristic c-src 60-kD band be- 
came progressively enriched during purification of the os- 
teoclasts (Fig.  1 A). pp60  ~-'~ was detectable only at much 
lower levels in the contaminating cells, which are mostly de- 
rived from bone  and bone  marrow  but also contain os- 
teoclasts, albeit at low numbers (Fig. 1 B). The amount of 
pp60  ~-s'~ in the most pure preparations of osteoclasts was 
greater than the level of the protein in homogenates of whole 
chicken brain, a tissue known to be rich in pp60  ~-s'~ (10), 
but less than the level in purified human platelets (Fig. 1 B). 
To determine on a  more quantitative basis the level of 
pp60  ~-'r~ activity in osteoclasts relative to other cell types, 
tyrosine kinase activity was assayed using enolase as a sub- 
strate. The results demonstrated (Fig. 1 C) that the level of 
pp60  ~-'~ kinase activity present in osteoclasts was compara- 
ble to the activity in brain and about one-quarter of the level 
in platelets (27 +  20%, n =  4). For comparison, it has been 
reported  that pp6(Y  ....  kinase  activity in  tissues  such  as 
muscle, spleen, thymus, and bone marrow are only 3-5 % of 
the activity in platelets, while activity in normal fibroblasts 
is <1% of that in platelets (19, 20). Furthermore, the assay 
showed that the pp60  ~-'~ kinase activity present in the initial 
unfractionated  bone cell preparations sedimented almost en- 
tirely with the osteoclast fraction and was barely detectable 
in  bone  marrow  and  other  bone  mononuclear  cells, 
confirming that the pp60  ~-'c in the initial bone cell prepara- 
tions is almost exclusively in the osteoclasts. 
Immunocytochemistry 
Further evidence of specific high expression of pp60  ~-s'~ in 
osteoclasts was obtained in immunocytochemical  analysis of 
normal neonatal rat and chicken bone. When immunoperox- 
idase staining with mAb 327 was performed, the osteoclasts 
were very strikingly labeled, in contrast to other bone cells 
(i.e., osteoclasts, osteocytes, cells lining the bone surfaces, 
and bone marrow cells) in which the amount of pp60  ~'~ 
was below the level of detection (Fig. 2, A and C). Among 
osteoclasts, pp60  ~-,,c appeared to be expressed at different 
levels, with some cells showing more intense staining than 
others (not shown), suggesting that the amounts of pp60  ~  .... 
in osteoclasts might differ, depending on the functional state 
of the cell. The high expression of pp60  ~-~ in osteoclasts 
relative to other bone cells was confirmed by immunofluo- 
rescence staining of bone tissue (Fig. 2 B). 
While it is known that pp60  ~-sr~ is bound to the cytoplas- 
mic surface of membranes via a myristic acid group at the 
NH2 terminus of the protein (6),  examination of the sec- 
tions at the EM level, although often suggesting enrichment 
close to the plasma membrane, failed to demonstrate restric- 
tion to a specific plasma membrane domain or to specific in- 
tracellular  membranes.  On  the contrary,  the  labeling  ap- 
peared to be distributed throughout the cytosol (Figs. 2  C 
and 3 A), including the ruffled border area (Fig. 3 C), sug- 
Home et al. Osteoclast pp60  ~'~  1005 Figure 1. Avian osteoclasts are enriched in pp6(F  -sr~. Osteoclasts were isolated from calcium-deprived hens as described in Materials and 
Methods.  (A) Preparations of increasing relative abundance of osteoclasts were solubflized in 0.5 % SDS.  Equal amounts of protein (100 
#g)  were subjected to SDS-PAGE and transferred to nitrocellulose  and the pp6(F  -'~ was detected by immunoblotting with mAb 327, 
demonstrating that pp60  r  copurifies with osteoclasts. Lane 1,  1 osteoclast (OC),  1,000 other cells; lane 2,  10C,  200 other cells; lane 
3,  10C, 50 other cells; lane 4,  10C, 5 other cells.  Positions of molecular mass standards are indicated in kilodaltons.  (B) Samples that 
were taken at different stages of the osteoclast purification, described in Materials and Methods, as well as chicken brain and human plate- 
lets, were solubilized in 0.5%  SDS.  Equal amounts of protein (100 #g) were subjected to SDS-PAGE, transferred to nitrocellulose, and 
immunoblotted with mAb 327. The results demonstrate that nearly all of the pp60  r  sediments with the osteoclasts.  Lane 1,  unfrac- 
tionated bone cells (10C, 500 other cells); lane 2, unsedimented cells after the first unit gravity sedimentation (<10C, 2,000 other cells); 
lane 3,  sedimented cells from the first unit gravity sedimentation (10C,  100 other ceils); lane 4,  final osteoclast preparation (10C,  5 
other cells); lane 5, chicken brain; lane 6, human platelets. (C) Src tyrosine kinase activity. Samples taken at different stages of the osteoclast 
purification, as well as chicken brain and human platelets, were assayed for src tyrosine kinase activity.  The cells were lysed with RIPA 
buffer, equal amounts of protein (250 #g) were immunoprecipitated with mAb 327, and the immunoprecipitates were assayed for tyrosine 
kinase activity by measuring 32p incorporation into enolase as described in Materials and Methods.  The results demonstrate that the src 
kinase activity sediments with the osteoclasts, and that the level of src kinase activity in osteoclasts is comparable to levels in brain and 
platelets. Lane 1, unfractionated bone cells (10C,  300 other ceils); lane 2, unsedimented cells after the first unit gravity sedimentation 
(<10C, 2,000 other cells); lane 3, sedimented cells from the first unit gravity sedimentation (10C,  100 other ceils); lane 4, final osteoclast 
preparation (10C,  7 other cells); lane 5,  chicken brain; lane 6, human platelets. 
gesting that c-src might be associated  with  multiple mem- 
branes within the osteoclast,  or even, as unlikely as it may 
seem, soluble in the cytosol. A  similarly diffuse pattern was 
also  observed  by  immunofluorescence  of  frozen  sections 
(Fig.  2 B).  Since this diffuse pattern could also result from 
the procedures we used, we then used immunogold and con- 
focal immunofluorescence techniques to localize pp60  ~-'r~ in 
osteoclasts.  Osteoclast pp60  ~~'c was only weakly labeled by 
immunogold, possibly due to limited access to the epitopes, 
but the results strongly suggested an association with mem- 
branes,  particularly  intraceUular membranes  (Fig.  3  B). 
To  further  analyze  the  distribution  of  pp60  ~-~  in  os- 
teoclasts, isolated cells were studied by confocal microscopy. 
For this purpose, isolated rat osteoclasts were allowed to ad- 
here to glass coverslips or to slices of bovine cortical bone, 
fixed, and stained with either mAb 327 or LA074. With both 
antibodies,  intracellular  staining was apparent and was dis- 
tributed throughout the cells in optical sections taken at vari- 
ous levels from the top of the cell to the level of attachment 
to the substrate (Fig. 4). A clearly punctate pattern of stain- 
ing was seen in osteoclasts on glass (Fig. 4, A, C-E), while 
the pattern in cells on bone was more diffuse (Fig. 4 B). A1- 
though an accumulation of stained particles was sometimes 
observed  along  the  cytoplasmic  face  of the plasma  mem- 
brane  (Fig.  4  C),  staining  of the  plasma  membrane  and 
lamellipodia was low or undetectable relative to the intracel- 
lular punctate  structures.  Most often,  the ppt0~-s'~-contain- 
ing structures were distributed unevenly through the cell in- 
terior,  usually  well separated  from the plasma membrane. 
SubceUular Fractionation 
To further  establish  the association  of pp60  ~-~rc with osteo- 
clast membranes, we then performed cell fractionation and 
examined  the level of the protein  by immunoblot analysis. 
We examined membrane and cytosol fractions prepared from 
purified osteoclasts, as described in Materials and Methods, 
for ppt0~-"q  As  shown  in  Fig.  5,  little  of the pp60  ~-s'c was 
present in the cytosol (lane 3).  Of the two membrane frac- 
tions, the 100,000-g pellet (lane 2), enriched in plasma mem- 
brane,  golgi,  and  endosomal  markers,  contained  more 
pp60  ~-s`~ than  the  10,000-g  pellet  (lane/),  which  was  en- 
riched in mitochondrial markers. These data confirmed that 
ppt0  ~  ....  is membrane associated in osteoclasts,  as in other 
cell types (1,  6,  11,  16,  22,  24,  31,  36-38). 
The Journal of Cell Biology, Volume  ll9,  1992  1006 Figure 2. pp61Y  ''~ is highly enriched in osteoclasts but not in other bone cells. Elevated expression of pp60 in osteoclasts (/arge arrows, 
A-C) but not other nearby cells (small arrows, B) in chick growth plate, demonstrated by immunoperoxidase staining (,4 and C) and im- 
munofluorescence of frozen sections (B) with mAb 327. With both techniques, pp60  ~-'~ was found to be distributed throughout the 
cytoplasm without apparent polarity (see also Fig. 3). Bars: (A) 5 ttm; (B) 20 #m; (C) 2/tin. 
Induction of c-src during Bone Marrow Differentiation 
Since it appeared that high levels of c-src expression con- 
stituted part of the phenotype of mature osteoclasts, we then 
investigated  whether  expression  of  the  c-src  gene  was 
specifically induced during the differentiation of this  cell 
type. Bone marrow cells from calcium-deprived chicks were 
cultured for 2-6 d in the presence or absence of 10  -8 M ex- 
ogenous  1,25(OH)2D3.  We  have  previously demonstrated 
that,  in this  culture system,  1,25(OH)2D3  induces  the ex- 
pression of several osteoclast markers (carbonic anhydrase 
II, vitronectin receptor, tartrate-resistant acid phosphatase, 
and  Na+/K  + ATPase) (5).  In the cells cultured with  1,25- 
(OH)2D3, the amount of pp60  ~-,'~ (Fig. 6) and src kinase ac- 
tivity (not shown) at day 4 was about two-fold greater than 
the level in untreated cells. However, the amount of pp60  ~-~ 
also increased over time in control cells, albeit at a slower 
rate  than  in  the  1,25(OH)2D3-treated  cells,  confirming  a 
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 previous report of increased expression of pp60  ~  .... and src 
kinase activity during marrow cell differentiation in the pres- 
ence of serum (18). When c-src mRNA was examined in 
cells cultured for 6 d with or without 1,25(OH)2D3, the lev- 
els were only slightly higher (20-80%) in the 1,25(OH)2Dr 
treated cells than in control cells (not shown). 
Src-related 1)~rosine Kinases 
Finally, we also screened for other members of  the src family 
that share some functional properties of pp60  ~-s~ (6), in or- 
der to determine whether the  apparent  sensitivity of os- 
teoclasts to mutation of the c-src gene could possibly be ex- 
plained by their  failure to  express  such  related  tyrosine 
kinases.  Tyrosine  kinase  assays  were  performed  on  os- 
teoclast lysates using antibodies in the immunoprecipitation 
step that are directed against unique sequences of individual 
src-related kinases (25, 28, 32).  In addition to pp60  ~  .... ki- 
nase  activity, c-fyn, c-lyn,  and  c-yes  kinase activity was 
detected (Fig. 7).  While the kinase activities of the other 
members of the family, c-blk, c-fgr, c-hck, and c-lck, were 
essentially absent, we cannot rule out the possibility that one 
or more are present at undetectable levels. The levels of ac- 
tivity of c-fyn, c-lyn, and c-yes in osteoclasts were 1-5 % of 
the pp60  ~-'~ kinase activity, similar to the relative activities 
of these kinases in human platelets. In immunocytochemical 
studies, osteoclasts were strongly stained by antibodies to 
c-yes, with an intracellular distribution similar to that seen 
for pp60  ~-'r~ stained with mAb 327 (Fig. 3 D). On the other 
hand, only weak staining was seen with antibodies to c-fyn 
and c-lyn. 
Discussion 
The report by Soriano et al. (41) that the src- mouse is os- 
teopetrotic was a dramatic demonstration that pp60  ~-s'~ plays 
a key role in osteoclast function. The aim of this study was 
to identify which bone cells expressed pp60~-'% and with 
what subceUular distribution, as a first step in analyzing the 
requirement for this protein in bone resorption.  Although 
our results do not address the issue of pp60~-'~'s functional 
role in bone  resorption,  they indicate that the protein  is 
specifically expressed  at high levels in the osteoclast,  as 
shown by immunocytochemistry, immunoblotting, and src 
kinase activity. Induction of differentiation of bone marrow 
mononuclear cells toward an osteoclast-like phenotype by 
treatment with 1,25(OH):D3  (4, 5, 33) led to higher levels 
of pp60  ~  .... than in untreated cells, further suggesting that 
osteoclasts are characterized by elevated c-src expression. 
These results clearly demonstrate a direct link between the 
osteoclast and c-src expression, and strongly suggest, but by 
no means prove, that the osteoclast may be the site of the 
specific defect in c-src- mice that leads to impaired osteo- 
clast function and osteopetrosis. This possibility is further 
supported by the ability of Soriano, Mundy, and colleagues 
to reverse the osteopetrotic condition of the src- mice by 
transplanting hematopoietic tissues (liver or bone marrow) 
from normal mice (Mundy, G.,  and P.  Soriano, personal 
communication). 
While this initial study did not attempt to identify specific 
functions of pp60  ~-'~ in osteoclastic bone resorption, some 
possibilities are suggested by considering the immunolocali- 
zation results and the known characteristics of the protein in 
other cells. As in other cells, the protein is virtually entirely 
membrane bound. Most striking is the fact that, although we 
cannot exclude the presence of lower levels of pp60 .... at the 
plasma membrane, the higher concentration of the protein is 
found at the limiting membrane of intracellular vesicles. 
This is in contrast to the situation in platelets, where the 
majority of the pp60  ~-'rc is associated with the plasma mem- 
brane and the membrane of the surface-connected canalicu- 
lar system (16). Both confocal and electron microscopy sug- 
gest that these vesicles are not distributed in any polarized 
fashion within the osteoclast. Interestingly, this pattern of 
staining is similar to what has been observed in cells derived 
from MDCK cells (48, 49), COS cells (26),  and NIH 3T3 
cells (12),  which overexpress pp60  ~-'~c after transfection. In 
the case of the overexpressing NIH cells, pp60  ~-src colocal- 
ized  in part  with vesicular components of the  endocytic 
pathway (12).  Although the possibility was raised that this 
distribution resulted from overexpression of the protein, our 
results in normal ceils, both in situ and on glass, suggest that 
the association of pp60  ~-src with vesicles found in the peri- 
nuclear region may be functionally significant. The associa- 
tion of pp60  ~  .... with secretory granules and vesicles has 
also been reported in platelets (37),  chromaflin cells (22, 
36), neurons (1, 24), and PC12 cells (31), further suggesting 
that the protein may contribute to vesicle targeting or mem- 
brane fusion. In the osteoclast, targeted delivery of intracel- 
lular vesicles to the apical surface of the cell is required to 
secrete enzymes into the resorption compartment and to in- 
sert the proton pump and other transporters involved in acid 
secretion at the apical ruffled border  membrane (2).  Al- 
though the apparent association of pp60  ~-src with intracellu- 
lar vesicles in the osteoclast is consistent with this possible 
function, further work will be required to clarify this issue. 
It has also been suggested that pp60  ~-s~c may be involved 
in integrin-related attachment and signal transduction mech- 
anisms, another potential role that is of particular interest 
with regard to osteoclasts. In platelets, inhibiting the binding 
of the  integrin GP  IIb-IIIa to  fibrinogen blocks  agonist- 
induced tyrosine kinase activity (21), while in epidermal car- 
cinoma cells, antibody-mediated clustering of integrin o~5/31 
activates  tyrosine kinases  (27).  In  osteoclasts,  integrins, 
specifically otv/~3 (the vitronectin receptor), are involved in 
bone resorption (13), probably mediating the attachment of 
the osteoclast to the bone matrix (52) and participating in the 
sealing-off  of the extracellular bone resorbing compartment. 
Although pp60 V-s~ is known to associate with focal points of 
adhesion in v-src-transformed fibroblasts (34, 40), pp60  ~-s'~ 
never appears in focal adhesion plaques or rosettes (podo- 
somes) in NIH cells that overexpress pp60  ~-'~ (12). In agree- 
ment with these results, our confocal microscopic results fail 
to  show  a  specific association of pp60  ~  .... with  adhesion 
structures. Integrin binding to bone matrix might neverthe- 
less involve pp60  ~-'r~ and provide a signal leading to the de- 
velopment of cell polarity and the formation of the ruffled 
border at the site of bone resorption. Consistent with such 
a possible involvement of protein tyrosine kinases in integrin 
function in osteoclasts, preliminary studies in our laboratory 
indeed suggest that a rapid, transient wave of tyrosine phos- 
phorylation is triggered in isolated osteoclasts upon exposure 
to RGD-containing peptides that bind to integrin. 
Redundancies in the functional associations of the several 
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is membrane associated.  Puri- 
fied osteoelasts  (10C, 6 other 
cells)  were homogenized and 
the  homogenates  were  frac- 
tionated by differential  centri- 
fugation as described in Mate- 
rials  and  Methods.  Proteins 
were solubilized in RIPA buffer 
and equal amounts of protein 
(100 #g) from the membrane 
and eytosol fractions were sub- 
jected to immunoprecipitation 
with mAb 327. The immuno- 
precipitates  were run on SDS- 
PAGE,  transferred  to  nitro- 
cellulose,  and  analyzed  by 
immnnoblot  with  biotinylated  mAb  327  and  [125I]streptavidin. 
The 100,000-g pellet is mostly highly enriched in pp6@s%  while 
the protein is not detected in the 100,000-g  supernatant.  Lane 1, 
10,000-g pellet;  lane 2, 100,000-g pellet;  lane 3, 100,000-g super- 
natant. 
Figure 6. Increased pp6@  -sr~ expression  during osteoclast differen- 
tiation.  Chick marrow mononuclear cells were cultured for 4 and 
6 d in the presence (+) or absence (-) of 10  -8 M  1,25(OH)2D3. 
The cells were harvested by gentle scraping and lysed in 0.5 % SDS. 
Equal amounts of  protein were subjected to SDS-PAGE, transferred 
to nitrocellulose,  and analyzed by immunoblot with mAb 327. Mo- 
lecular weight markers are indicated  in kilodaltons.  The amount of 
pp6@  -sr~ is  increased when cells  are cultured in the presence of 
1,25(OH)2D3. 
Figure  7.  Osteoclasts  express  other members  of the src family. 
Equal amounts of protein (100 #g for src, 200 #g for the other ki- 
nases) from lysates of chicken osteoclasts  (A) and human platelets 
(B) solubilized with RIPA  buffer were immunoprecipitated with an- 
tibodies against individual members of  the src family or with rabbit 
anti-mouse IgG (RAM), and the immunoprecipitated material  was 
assayed  for tyrosine kinase  activity as in Fig.  1 C. 
members of the src family present in platelets and neurons 
(23,  25, 44) could potentially explain the absence of gross 
alteration  of platelet  and  nervous  system  function  in  the 
c-src- transgenic mice (41).  The apparent specificity of the 
bone resorption defect in the c-src- mice implied either that 
bone cells lack other src-like proteins that could fill the func- 
tional  role of pp6@  -src, or that the protein  performs  some 
function that is specific to both pp6@  -src and bone cells.  To 
address this issue,  we tested osteoclast preparations for the 
presence of other members of the src family that are known 
to  share  certain  functional  properties  with  pp60  "-src (28). 
The presence of  three other members of  the src family, c-fyn, 
c-lyn, and c-yes, in osteoclasts, and at levels comparable to 
the  levels  in  platelets  or  brain,  clearly  indicates  that  the 
resorption  defect  in  the  src-  mouse  cannot  be  explained 
simply by the absence of other src-like proteins.  The pres- 
ence in osteoclasts of these members of the src family also 
demonstrates that the scope of the contribution of nonrecep- 
tor tyrosine kinases  to osteoclast function extends  beyond 
pp60c-'% notwithstanding the dramatic effect of the deletion 
of the c-src gene on bone resorption.  The degree of func- 
tional redundancy of these enzymes in the osteoclast, as well 
as in other cell types, remains to be determined,  and func- 
tions that are unique to pp60  ~  .... are likely points at which 
the deletion  of the  c-src gene has  its  deleterious  effect on 
bone resorption.  Further support for a specific requirement 
for pp6@  .... in bone resorption and remodeling is provided 
by the fact that fyn- and yes- mice generated by the Soriano 
laboratory are not osteopetrotic (Soriano, P., personal com- 
munication). 
In  summary,  pp60"  ....  is  expressed  at  high  levels  in  os- 
Figure 4. Intracellular vesicles in osteoclasts  are highly enriched in pp6@  -sr~. Confocal immunofluorescence localization of pp60  ~-'r~ in iso- 
lated rat osteoclasts  on glass (A, C, D, E, stained  with LA074) and bone (B, stained  with mAb 327).  In A and B, 0.6-#m optical sections 
were taken progressively from near the top of the cell (upper left) to the level of attachment to the substratum (lower right), showing that 
the punctate (A) or more diffuse (B) staining  of pp60  `s'~ is distributed  throughout the cell, without apparent polarity.  In the cells on glass 
(A,  C-E), the staining  pattern is distinctly  punctate,  often surrounding small  circular unstained regions.  In C and D, the predominant 
localization is toward the center of the cell (left, in D).  The images  are pseudocolor projections; bars indicate  the relative  intensity  of 
staining,  with low intensity  indicated  by blue and purple and high intensity  indicated  by yellow and red.  Bars: (A) 30 #m; (B) 40 #m; 
(C) 22 #m; (E) 35 #m. For D, the bar in C is  10 #m. 
Home et al. Osteoclast  pp60  :~  1011 teoclasts, where it is predominantly associated with intracel- 
lular membranes. Although further work will be required to 
determine the role of pp60  ~-src in osteoclasts,  these results 
demonstrate a direct link between the osteoclast and c-src ex- 
pression, and may help explain the fact that targeted disrup- 
tion of this protooncogene leads to impaired function and os- 
teopetrosis. 
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